Scientists develop refined diagnostic tool for inherited dementias

September 16, 2013, Medical Research Council

Researchers at the Medical Research Council (MRC) have developed and tested a more efficient and cost effective way to diagnose early onset, genetic forms of dementia.

Scientists and doctors at the MRC Prion Unit and the National Institute of Health Research (NIHR) Queen Square Dementia Biomedical Research Unit (BRU) have developed an integrated diagnostic tool (the 'MRC Dementia Gene Panel') which brings together for the first time all 17 genes known to play a substantial role in causing inherited forms of .

Using a modern method of analysing the genetic material or DNA from a patient's , called 'next generation sequencing', they were able to look for abnormalities in all of these genes simultaneously, quickly and cheaply. Their work, published online this week in the journal Neurobiology of Aging, shows that the technology is highly accurate and comprehensively identified the .

Dementia is one of the most important healthcare challenges worldwide. Some forms of dementia, particularly in younger people, run in families and are caused by one or more being passed down from parent to child. While these forms are relatively uncommon and are currently thought to account for around two per cent of all dementias, they can be detected and diagnosed definitively by genetic testing. The technique will be used at University College London Hospitals NHS Foundation Trust (UCLH) to offer improved diagnosis to in their neurogenetics clinics. The researchers will also use this technology to study further the relevance of these genes as a tool in the diagnosis of patients with dementia, particularly for those developing dementia before the age of 65 where a genetic cause of their illness is more likely.

There has been significant progress in the understanding of the of dementia in recent years. Genetic mutations in more than 17 genes are known to cause specific types of dementias while other changes in these and other genes can increase a person's risk of developing dementia over the course of their lifetime. Although these genes account for only a small minority of the total number of patients with dementia, a simple blood test could provide a definitive diagnosis, and may lead to the opportunity for blood relatives to find out if they share an increased risk of developing the disease.

Dr Simon Mead, who led the research at the MRC Prion Unit and the NIHR Dementia BRU, said,

"We have developed this technology because we know many patients don't get an accurate diagnosis. We hope that this and related technologies will greatly improve the way we identify patients with genetic forms of dementia. Currently the tests for dementia genes are not widely available for doctors and, where they are available, the tests have been very expensive and it is hard sometimes to know who needs to be tested. What is really needed is a simple and cost effective way to screen all at the same time, which could be used in a larger proportion of patients. It is likely that screening more patients in this way will pick up genetic causes that might otherwise be missed."

Professor Martin Rossor, BRU Director, said,

"'This technology will revolutionise our ability to provide a rapid and cost effective diagnosis. It will be particularly important for those patients with a diagnosis of young onset dementia and their families. There is estimated to be over 18,000 people in the UK below the age of 65 with dementia and it is this young onset group that often has a family history of disease."

Dr Catherine Elliott, Head of Neurosciences and Mental Health at the MRC, said:

"Tackling dementia is a priority for the MRC and improving methods of diagnosis is crucial for truly understanding the burden of these devastating diseases. This is a significant development in applying new technology to improve in those groups of patients with genetic causes of dementia."

Explore further: Dementia sufferers more likely to be diagnosed with urinary or fecal incontinence

Related Stories

Dementia sufferers more likely to be diagnosed with urinary or fecal incontinence

August 27, 2013
Patients with a diagnosis of dementia have approximately three times the rate of diagnosis of urinary incontinence, and more than four times the rate of fecal incontinence, compared with those without a diagnosis of dementia, ...

New innovative training to improve the care of people with dementia in general hospitals

September 11, 2013
Academics and healthcare professionals from across Greater Manchester as well as people with a diagnosis of dementia and family carers have teamed up to devise a new training programme for general hospital staff.

High dose statins prevent dementia

September 1, 2013
High doses of statins prevent dementia in older people, according to research presented at the ESC Congress today by Dr. Tin-Tse Lin from Taiwan. The study of nearly 58,000 patients found that high potency statins had the ...

Screening for minor memory changes will wrongly label many with dementia, warn experts

September 10, 2013
A political drive led by the UK and US to screen older people for minor memory changes (often called mild cognitive impairment or pre-dementia) is leading to unnecessary investigation and potentially harmful treatment for ...

Dementia patients need urgent support after diagnosis

November 1, 2012
There is an urgent need for support from outside the family after diagnosis of dementia according to a study led by researchers from the University of Hertfordshire.

Acting out dreams linked to development of dementia, study finds

March 21, 2013
The strongest predictor of whether a man is developing dementia with Lewy bodies—the second most common form of dementia in the elderly—is whether he acts out his dreams while sleeping, Mayo Clinic researchers have discovered. ...

Recommended for you

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.